Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3995
Revised: April 26, 2024
Accepted: May 22, 2024
Published online: July 6, 2024
Processing time: 114 Days and 1.9 Hours
Owing to the advancement in bacterial identification techniques, the detection rate of non-tuberculous mycobacterium (NTM) has been on the rise. Different from Mycobacterium tuberculosis, the clinical symptoms of NTM are not easily detected, and the clinical efficacy and prognosis are somewhat heterogeneous. To report a case of Mycobacterium gordoniasis of cervical lymph node diagnosed in Anhui Chest Hospital in July 2022.
Upon examination, the patient who weighed 67.5 kg, was human immunodeficiency virus negative, healthy, without hypertension, diabetes, heart disease and other basic diseases microscopic analysis revealed granulomatous inflammation with coagulation necrosis in the lymphocyte, and tuberculosis was not ruled out. Plain computed tomography scans of the neck and chest indicated the presence of a single grayish-yellow and grayish-brown tissue, the dimensions of which was top of form 10.5 cm × 3.0 cm × 1.5 cm. After pathological consultation in our hospital, the diagnosis was confirmed as NTM infection.
This case report and the clinical epidemiological research on improving NTM have important guiding significance for improving decision-making in clinical treatments.
Core Tip: This case highlights the growing challenge of diagnosing and managing non-tuberculous mycobacterium (NTM) infections, with an emphasis on Mycobacterium gordoniasis in the cervical lymph node. This underscores the significance of employing sophisticated bacterial identification methods to differentiate NTM from tuberculosis, considering their nuanced clinical presentations and implications for treatment approaches. The report serves as a pivotal reminder of the diverse clinical outcomes linked to NTM infections, advocating for increased vigilance and personalized therapeutic interventions in analogous scenarios.